Literature DB >> 10065637

Immune responses to the radiation-attenuated schistosome vaccine: what can we learn from knock-out mice?

R A Wilson1, P S Coulson, A P Mountford.   

Abstract

The goal of an effective schistosomiasis vaccine has proved elusive but the protective immunity induced in mice by radiation-attenuated cercaria larvae provides an appropriate model from which such a vaccine might be developed. Using gene-disrupted mice, we have analysed the process of immune priming by attenuated larvae of Schistosoma mansoni and the nature of the pulmonary effector response directed against a challenge infection. Vaccination stimulates expansion of IFNgamma-producing T-helper cells in the skin-draining lymph nodes. IL-12 is crucial in determining the Thl direction of this initial response but the cells of origin and the parasite components which stimulate its production are unknown. In the effector response, focal aggregates comprising mainly mononuclear cells accumulate around challenge larvae in the lungs, a process orchestrated by IFNgamma. This cytokine up-regulates nitric oxide synthase activity but we were unable to implicate nitric oxide as a cytotoxic agent causing challenge parasite elimination. An alternative action for IFNgamma may be to up-regulate adhesion molecule expression, increasing the cohesiveness of effector foci the better to block parasite migration, but the adhesive interactions so far examined do not appear relevant. In contrast, TNF induction is essential to protection, and we are currently testing the hypothesis that it determines the speed of the effector response following arrival of challenge larvae in the lungs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10065637     DOI: 10.1016/s0165-2478(98)00134-5

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  16 in total

Review 1.  A history of hookworm vaccine development.

Authors:  Brent Schneider; Amar R Jariwala; Maria Victoria Periago; Maria Flávia Gazzinelli; Swaroop N Bose; Peter J Hotez; David J Diemert; Jeffrey M Bethony
Journal:  Hum Vaccin       Date:  2011-11-01

2.  Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacy.

Authors:  Weidong Zhang; Adebayo J Molehin; Juan U Rojo; Justin Sudduth; Pramodh K Ganapathy; Eunjee Kim; Arif J Siddiqui; Jasmin Freeborn; Souad R Sennoune; Jordan May; Samra Lazarus; Catherine Nguyen; Whitni K Redman; Gul Ahmad; Workineh Torben; Souvik Karmakar; Loc Le; Kameswara R Kottapalli; Pratibha Kottapalli; Roman F Wolf; James F Papin; David Carey; Sean A Gray; Jenn D Bergthold; Raymond T Damian; Bryan T Mayer; Florian Marks; Steven G Reed; Darrick Carter; Afzal A Siddiqui
Journal:  Ann N Y Acad Sci       Date:  2018-08       Impact factor: 5.691

3.  SjTat-TPI facilitates adaptive T-cell responses and reduces hepatic pathology during Schistosoma japonicum infection in BALB/c mice.

Authors:  Wenyue Zhang; Xiaofeng Luo; Fan Zhang; Yuxiao Zhu; Bingya Yang; Min Hou; Zhipeng Xu; Chuanxin Yu; Yingying Chen; Lin Chen; Minjun Ji
Journal:  Parasit Vectors       Date:  2015-12-30       Impact factor: 3.876

Review 4.  Schistosomiasis in the People's Republic of China: prospects and challenges for the 21st century.

Authors:  A G Ross; A C Sleigh; Y Li; G M Davis; G M Williams; Z Jiang; Z Feng; D P McManus
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

5.  IFN-inducible p47 GTPases display differential responses to Schistosoma japonicum acute infection.

Authors:  Xuesong Chen; Xiaotang Du; Meijuan Zhang; Donghui Zhang; Minjun Ji; Guanling Wu
Journal:  Cell Mol Immunol       Date:  2009-12-23       Impact factor: 11.530

Review 6.  Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour.

Authors:  R Alan Wilson; Patricia S Coulson
Journal:  Trends Parasitol       Date:  2009-08-28

7.  In the absence of CD154, administration of interleukin-12 restores Th1 responses but not protective immunity to Schistosoma mansoni.

Authors:  James P Hewitson; Paul A Hamblin; Adrian P Mountford
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

Review 8.  The innate allergenicity of helminth parasites.

Authors:  Franco H Falcone; Alex Loukas; Rupert J Quinnell; David I Pritchard
Journal:  Clin Rev Allergy Immunol       Date:  2004-02       Impact factor: 8.667

9.  Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.

Authors:  Adebayo J Molehin; Souad R Sennoune; Weidong Zhang; Juan U Rojo; Arif J Siddiqui; Karlie A Herrera; Laura Johnson; Justin Sudduth; Jordan May; Afzal A Siddiqui
Journal:  Parasitol Res       Date:  2017-10-12       Impact factor: 2.289

Review 10.  Do schistosome vaccine trials in mice have an intrinsic flaw that generates spurious protection data?

Authors:  R Alan Wilson; Xiao-Hong Li; William Castro-Borges
Journal:  Parasit Vectors       Date:  2016-02-17       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.